Ignite Creation Date:
2025-12-24 @ 9:28 PM
Ignite Modification Date:
2025-12-31 @ 2:08 AM
Study NCT ID:
NCT03851432
Status:
UNKNOWN
Last Update Posted:
2020-07-16
First Post:
2019-02-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Janagliflozin Treat Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Metformin
Sponsor:
Sihuan Pharmaceutical Holdings Group Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-30
Start Date Type:
ACTUAL
Primary Completion Date:
2020-04-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2019-02-20
First Submit QC Date:
None
Study First Post Date:
2019-02-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-14
Last Update Post Date:
2020-07-16
Last Update Post Date Type:
ACTUAL